alexa Mesenchymal Stem Cells Protect From Acute Liver Injury By Attenuating Hepatotoxicity Of Liver NKT Cells In IDO Dependent Manner
ISSN: 1745-7580

Immunome Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

8th Molecular Immunology and Immunogenetics Congress
March 20-21, 2017 Rome, Italy

Bojana Simovic Markovic, Marina Gazdic, Aleksandar Arsenijevic, Ana Volarevic, Valentin Djonov, Nebojsa Arsenijevic, Miodrag Stojkovic, Miodrag L Lukic and Vladislav Volarevic
University of Kragujevac, Serbia
University of Bern, Switzerland
Posters & Accepted Abstracts: J Immunome Res
DOI: 10.4172/1745-7580.C1.012
Statement of the Problem: The effects of mesenchymal stem cells (MSCs) on phenotype and function of natural killer T (NKT) cells, is not understood. The aim of the study is to evaluate the protective nature of MSCs against acute liver injury through attenuating hepatotoxicity of liver NKT cells in IDO dependent manner. Methodology & Theoretical Orientation: We used concanavalin A (ConA) and α-galactosylceramide (α-GalCer) induced liver injury to evaluate effects of MSCs on NKT-dependent hepatotoxicity. Findings: MSCs significantly reduced Con A- and α-GalCer-mediated liver damage in C57Bl/6 mice, as demonstrated by histopathological analysis and liver enzyme tests, attenuated influx of inflammatory (T-bet+ TNF-α, IFN-γ producing as well as GATA3+, IL-4-producing) liver NKT cells and down-regulated TNF-α, IFN-γ and IL-4 levels in the sera of injured mice. It was observed that the liver NKT cells cultured in vitro with MSCs produced lower amounts of inflammatory cytokines (TNF-α, IFN-γ, IL- 4) and higher amounts of immunosuppressive IL-10 upon α-GalCer stimulation. MSC treatment attenuated expression of apoptosisinducing ligands on liver NKT cells suppressed the expression of pro-apoptotic genes in the livers of α-GalCer-treated mice. MSCs reduced cytotoxicity of liver NKT cells against HepG2 hepatocyte cells in vitro. The presence of 1-methyl-DL-tryptophan, a specific inhibitor of indoleamine 2,3-dioxygenase (IDO), in MSC-conditioned medium injected to α-GalCer-treated mice, counteracted the hepatoprotective effect of MSCs in vivo, and restored pro-inflammatory cytokine production and cytotoxicity of NKT cells in vitro. In line with these findings, human MSCs in an IDO-dependent manner, attenuated the production of inflammatory cytokines in α-GalCer-stimulated human peripheral blood mononuclear cells and reduced their cytotoxicity against HepG2 cells. Conclusion & Significance: MSCs protects the acute liver injury by attenuating cytotoxicity and capacity of liver NKT cells to produce inflammatory cytokines in IDO dependent manner.

Bojana Simovic Markovic has experience in immunopathology of liver and gastrointestinal tract research. She has a broad spectrum of publications including original article in the field of mesenchymal stem cell-dependent modulation of immune mediated diseases.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version